Advances in Nutrition · Nov 5, 2026

Research and Clinical Considerations for Continuous Glucose Monitoring in Healthy Populations

By Bellissimo N, Kucab M, Sievenpiper JL et al.

The expanding availability of continuous glucose monitors (CGMs) has generated growing interest in their application beyond diabetes management, particularly in healthy individuals seeking to optimize metabolic health through personalized nutrition. In May 2025, the Institute for the Advancement of Food and Nutrition Sciences (IAFNS) convened a multidisciplinary expert workshop to examine the scientific, methodological, and clinical considerations surrounding continuous glucose monitor (CGM) application in healthy populations. Discussions addressed normal glycemic physiology, determinants of postprandial glycemic responses (PPGRs), CGM use and functional health outcomes, research applications, and implications for clinical practice. The purpose of this initiative was to develop a perspective paper that synthesizes current evidence and provides guidance on these key considerations to inform responsible research, clinical interpretation, and future policy related to CGM use in populations who do not have diabetes mellitus. Evidence discussed during the workshop underscored substantial inter- and intra-individual variability in PPGRs driven by complex interactions among dietary composition, lifestyle behaviors, and physiological characteristics. CGMs offer the ability to capture these dynamics under real-world conditions and may help identify meaningful individual differences, particularly as PPGRs are increasingly recognized as sensitive markers of early disturbances in glucose regulation. However, important limitations constrain interpretation in healthy populations, including analytical variability, limited precision for single-meal or acute assessments, lack of standardized research protocols and consensus guidance, and insufficient evidence linking CGM-derived metrics to long-term clinical outcomes. High-quality randomized controlled trials, standardized protocols, consensus guidance and integrated metabolic frameworks are needed to determine the clinical relevance of CGM use in healthy populations. Until such evidence is established, CGM use outside of diabetes care should be approached cautiously and ideally within structured research or in clinical contexts that provide appropriate education and professional oversight. Statement of Significance This perspective addresses an important and timely gap in nutrition and health research by evaluating the scientific considerations, methodological limitations, and clinical implications of CGM use in individuals living without diabetes. This paper provides important insights and considerations for the potential integration of CGMs into personalized nutrition research and practice.

doi.org/10.1016/j.advnut.2026.100763Open accessPubMed 42988227Industry & policy

AgingResearch.News